Premium Nahrungsergänzungsmittel | artgerecht

TNM Classification: Explanation and Cancer Stages

The TNM classification is an internationally recognized system for describing the extent of cancer based on tumor size, lymph node involvement, and distant metastases.

Regular tips about health Regular tips about health

Things worth knowing about "TNM Classification"

The TNM classification is an internationally recognized system for describing the extent of cancer based on tumor size, lymph node involvement, and distant metastases.

What Is the TNM Classification?

The TNM classification is a globally used system for the standardized description and staging of cancer. It was developed by the Union for International Cancer Control (UICC) and is maintained jointly with the American Joint Committee on Cancer (AJCC). The purpose of the classification is to describe the extent of a malignant disease in a uniform way, supporting treatment decisions, prognosis estimation, and comparability across clinical studies worldwide.

Meaning of T, N, and M

The three letters of the TNM system each represent a key characteristic of a cancer diagnosis:

T (Tumor): Describes the size and local extent of the primary tumor. The scale ranges from T0 (no primary tumor detectable) to T4 (large tumor or extensive invasion of surrounding tissues). Tis denotes carcinoma in situ, a non-invasive early-stage tumor.
N (Node/Lymph nodes): Indicates whether and to what extent regional lymph nodes are involved. N0 means no regional lymph node involvement, while N1 to N3 describe increasing degrees of lymph node spread.
M (Metastasis): Indicates whether distant metastases are present -- meaning whether tumor cells have spread to distant organs or tissues. M0 means no distant metastases, and M1 confirms their presence.

Prefixes and Additional Descriptors

The TNM system uses various prefixes and suffixes to clarify the context of the assessment:

c (clinical): The staging is based on clinical examinations, imaging, or biopsies prior to surgery (e.g., cT2N1M0).
p (pathological): The staging is determined after surgical removal and histological examination of the tumor (e.g., pT3N0M0).
y (post-treatment): Used when classification follows prior treatment such as chemotherapy or radiation therapy.
r (recurrence): Marks a tumor that has recurred after a disease-free interval.
m (multiple): Indicates the presence of multiple synchronous primary tumors.

Tumor Stages (UICC Staging)

Based on the TNM values, an overall UICC tumor stage is assigned, ranging from Stage I (locally confined tumor, favorable prognosis) to Stage IV (distant metastases present, more limited prognosis). Stage 0 refers to carcinoma in situ. This staging system is particularly important for treatment planning, as it is closely linked to available therapeutic options and expected survival rates.

Clinical Relevance

The TNM classification plays a central role in oncology:

It enables uniform communication between physicians, hospitals, and research institutions worldwide.
It forms the basis for treatment decisions, such as whether surgery, radiation, chemotherapy, or a combination is recommended.
It allows for prognostic assessment for the individual patient.
It facilitates the comparability of clinical trials and cancer registries.

The TNM classification is regularly updated to incorporate new scientific evidence. The current version is the 9th Edition of the UICC TNM Classification (2024).

Tumor-Specific Considerations

Specific TNM criteria exist for different cancer types, tailored to the anatomy and biological behavior of each tumor. For example, the T categories differ significantly between breast cancer, lung cancer, and colorectal cancer. In addition to the TNM system, further prognostic factors are used for certain tumor entities, such as the Gleason score in prostate cancer or hormone receptor status in breast cancer.

References

Brierley JD, Gospodarowicz MK, Wittekind C. (Eds.) - TNM Classification of Malignant Tumours, 8th Edition. UICC / Wiley-Blackwell, 2017.
Wittekind C. (Ed.) - TNM Classification of Malignant Tumours, 9th Edition. UICC / Wiley-VCH, 2024.
Union for International Cancer Control (UICC) - TNM Classification. Available at: https://www.uicc.org/resources/tnm

Building Blocks for a Healthy Life

As an integrated manufacturer, we develop & produce evidence-based, patented, and non-patented formulations. We work exclusively with plant and natural extracts according to the strictest purity & quality standards.
The combination of science & modern technology with the laws of nature creates solutions consistently tailored to humans – for the highest good: health.